Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 May 24 424B3 Prospectus supplement
- 11 Mar 24 EFFECT Notice of effectiveness
- 1 Mar 24 POS AM Prospectus update (post-effective amendment)
- 8 Nov 23 424B3 Prospectus supplement
- 4 May 23 424B3 Prospectus supplement
- 27 Mar 23 EFFECT Notice of effectiveness
-
23 Mar 23 POS AM Prospectus update (post-effective amendment)
- 9 Nov 22 424B3 Prospectus supplement
- 3 Aug 22 424B3 Prospectus supplement
- 27 Jun 22 424B3 Prospectus supplement
- 27 Jun 22 EFFECT Notice of effectiveness
- 14 Jun 22 S-1 IPO registration
GOVX similar filings
- 1 Mar 24 Prospectus update (post-effective amendment)
- 23 Mar 23 Prospectus update (post-effective amendment)
- 23 Mar 23 Prospectus update (post-effective amendment)
- 23 Mar 23 Prospectus update (post-effective amendment)
- 9 Mar 22 Prospectus update (post-effective amendment)
- 9 Mar 22 Prospectus update (post-effective amendment)
- 24 Mar 21 Prospectus update (post-effective amendment)
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Post-Effective Amendment No. 1 to the Registration Statement (No. 333-265583) on Form S-1 of GeoVax Labs, Inc. of our report dated March 23, 2023, relating to the 2022 consolidated financial statements and schedule of GeoVax Labs, Inc. which report expresses an unqualified opinion, appearing in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ WIPFLI LLP
Atlanta, Georgia
March 23, 2023